Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Monitoring the quality of medicines: results from Africa, Asia, and South America.

Hajjou M, Krech L, Lane-Barlow C, Roth L, Pribluda VS, Phanouvong S, El-Hadri L, Evans L, Raymond C, Yuan E, Siv L, Vuong TA, Boateng KP, Okafor R, Chibwe KM, Lukulay PH.

Am J Trop Med Hyg. 2015 Jun;92(6 Suppl):68-74. doi: 10.4269/ajtmh.14-0535. Epub 2015 Apr 20.

2.

Were medicine quality and pharmaceutical management contributing factors in diminishing artemisinin efficacy in Guyana and Suriname?

Pribluda VS, Evans L 3rd, Barillas E, Marmion J, Lukulay P, Chang J.

Malar J. 2014 Mar 3;13:77. doi: 10.1186/1475-2875-13-77.

3.

Implementation of basic quality control tests for malaria medicines in Amazon Basin countries: results for the 2005-2010 period.

Pribluda VS, Barojas A, Añez A, López CG, Figueroa R, Herrera R, Nakao G, Nogueira FH, Pianetti GA, Povoa MM, Viana GM, Gomes MS, Escobar JP, Sierra OL, Norena SP, Veloz R, Bravo MS, Aldás MR, Hindssemple A, Collins M, Ceron N, Krishnalall K, Adhin M, Bretas G, Hernandez N, Mendoza M, Smine A, Chibwe K, Lukulay P, Evans L 3rd.

Malar J. 2012 Jun 15;11:202. doi: 10.1186/1475-2875-11-202.

4.

Synthesis and structure-activity relationships of 16-modified analogs of 2-methoxyestradiol.

Agoston GE, Shah JH, Lavallee TM, Zhan X, Pribluda VS, Treston AM.

Bioorg Med Chem. 2007 Dec 15;15(24):7524-37. Epub 2007 Sep 14.

PMID:
17910916
5.
6.

Withaferin A is a potent inhibitor of angiogenesis.

Mohan R, Hammers HJ, Bargagna-Mohan P, Zhan XH, Herbstritt CJ, Ruiz A, Zhang L, Hanson AD, Conner BP, Rougas J, Pribluda VS.

Angiogenesis. 2004;7(2):115-22.

PMID:
15516832
7.

Identification and characterization of a very low density lipoprotein receptor-binding peptide from tissue factor pathway inhibitor that has antitumor and antiangiogenic activity.

Hembrough TA, Ruiz JF, Swerdlow BM, Swartz GM, Hammers HJ, Zhang L, Plum SM, Williams MS, Strickland DK, Pribluda VS.

Blood. 2004 May 1;103(9):3374-80. Epub 2004 Jan 22.

PMID:
14739228
8.

Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism.

Hembrough TA, Swartz GM, Papathanassiu A, Vlasuk GP, Rote WE, Green SJ, Pribluda VS.

Cancer Res. 2003 Jun 1;63(11):2997-3000.

9.

2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF.

Mabjeesh NJ, Escuin D, LaVallee TM, Pribluda VS, Swartz GM, Johnson MS, Willard MT, Zhong H, Simons JW, Giannakakou P.

Cancer Cell. 2003 Apr;3(4):363-75.

10.

Dose-response effects of 2-methoxyestradiol on estrogen target tissues in the ovariectomized rat.

Sibonga JD, Lotinun S, Evans GL, Pribluda VS, Green SJ, Turner RT.

Endocrinology. 2003 Mar;144(3):785-92.

PMID:
12586754
11.

2-methoxyestradiol up-regulates death receptor 5 and induces apoptosis through activation of the extrinsic pathway.

LaVallee TM, Zhan XH, Johnson MS, Herbstritt CJ, Swartz G, Williams MS, Hembrough WA, Green SJ, Pribluda VS.

Cancer Res. 2003 Jan 15;63(2):468-75.

12.

2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta.

LaVallee TM, Zhan XH, Herbstritt CJ, Kough EC, Green SJ, Pribluda VS.

Cancer Res. 2002 Jul 1;62(13):3691-7.

13.

2-Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate.

Pribluda VS, Gubish ER Jr, Lavallee TM, Treston A, Swartz GM, Green SJ.

Cancer Metastasis Rev. 2000;19(1-2):173-9. Review.

PMID:
11191057
14.

A good estrogen.

Pribluda VS, Green SJ.

Science. 1998 May 15;280(5366):987-8. No abstract available.

PMID:
9616086
16.

Transphosphorylation as the mechanism by which the high-affinity receptor for IgE is phosphorylated upon aggregation.

Pribluda VS, Pribluda C, Metzger H.

Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11246-50.

17.

Transmembrane signaling by the high-affinity IgE receptor on membrane preparations.

Pribluda VS, Metzger H.

Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11446-50.

18.

IgE receptor-mediated hydrolysis of phosphoinositides by cytoplasts from rat basophilic leukemia cells.

Dreskin SC, Pribluda VS, Metzger H.

J Immunol. 1989 Jun 15;142(12):4407-15.

PMID:
2542411

Supplemental Content

Loading ...
Support Center